The widespread nature of identified MRPs in this setting suggests that various approaches to minimizing these problems and mitigating the associated burden on the health care system are warranted.

Background Pharmaceutical reforms were introduced to South Australia in 2007 and resulted in significant changes to the provision of medications on discharge for postnatal women. Women are required to pay for each medication provided on discharge, where previously these were free of charge. Aim To determine whether postnatal women discharged from the Women's and Children's Hospital purchased recommended non‐prescription medications. Method Postnatal women who delivered over a 3‐week period (May to June 2010) completed a short questionnaire during a home visit by a midwife in the days following discharge. The questionnaire collected data on demographics, as well as on medications supplied on discharge, whether non‐prescription medications were recommended to be purchased post‐discharge and whether these medications were purchased. Results 70 questionnaires were returned and analysed (response rate 30%). 110 non‐prescription medications were recommended for purchase post‐discharge; 42 were not purchased because they were present at home. Of the remainder, 42 (62%) were purchased and 26 (38%) were not purchased. The most common reason for medications not being purchased was that it was no longer required (59%). Medications purchased most often included iron (83%) and vitamin D (100%), while those purchased least often included urinary alkalinisers (33%) and fibre supplements (44%). Conclusion Pharmaceutical reforms do not appear to have had an adverse impact on non‐prescription medication management in postnatal women. The majority of non‐prescription medications were purchased as recommended post‐discharge.